Therefore our findings here, in conjuction with previous studies (Ma et al., 2012), suggest that the natural peptide and GLP-1 cleavage product GLP-1 (9-36) has therapeutic potential to improve cognition in DS and other neuronal diseases associated with excessive mitochondrial ROS. This evidence concerns the gene GLP1R and Dravet syndrome.